Pay in 4 interest-free payments of $20.00 Learn more
Ships within 48 hours · Estimated delivery Aug 11 - Aug 16
BMS-708163 decreased CSF Aβ40 and Aβ42 approximately 30% following daily dose of 100 mg after 28 days and by 60% at daily dose of 150 mg
JNK Inhibitor XVI
InChiKey: OYYVWNDMOQPMGE-SDQBBNPISA-N
measured in vitro
Azilsartan (medoxomil monopotassium) Catalog No.:M9532-2 BMS-708163 decreased CSF Aβ40 andAzilsartan medoxomil is a prodrug, is hydrolyzed to azilsartan in the gastrointestinal tract during absorption. Azilsartan is a selective AT1 subtype angiotensin II receptor antagonist. Azilsartan blocks the vasoconstrictor and aldosteronesecreting effects of angiotensin II by selectively blocking the binding of angiotensin II to the AT1 receptor in many tissues, such as vascular smooth muscle and the adrenal gland. Its action is, therefore,
US$ 19.99
US$ 5625.24
US$ 28.00
US$ 24.99
US$ 7136.50
Sold : Login>>